Publications

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Henao-Restrepo, AM; Longini, IM; Egger, M; Dean, NE; EDMUNDS, WJ; CAMACHO, A; Carroll, MW; Doumbia, M; Draguez, B; Duraffour, S; Enwere, G; Grais, R; Gunther, S; Hossmann, S; Kondé, MK; Kone, S; Kuisma, E; Levine, MM; Mandal, S; Norheim, G; Riveros, X; Soumah, A; Trelle, S; Vicari, AS; WATSON, CH; ... Røttingen, J-A.

2015

Lancet, (2015).386 9996 10.1016/S0140-6736(15)61117-5.

Ebola vaccination - Authors' reply.

Longini, IM; Egger, M; Dean, NE; EDMUNDS, WJ; Henao-Restrepo, AM; Study steering group,;

2015

Lancet, (2015).386 10012 10.1016/S0140-6736(15)00951-4.

The impact of childhood vaccines on bacterial carriage in the nasopharynx: a longitudinal study.

BOTTOMLEY, C; BOJANG, A; SMITH, PG; Darboe, O; ANTONIO, M; FOSTER-NYARKO, E; KAMPMANN, B; GREENWOOD, B; D'ALESSANDRO, U; ROCA, A;

2015

Emerging themes in epidemiology, (2015).12 1 10.1186/s12982-014-0022-3.

Prevention of bacterial infections in the newborn by pre-delivery administration of azithromycin: Study protocol of a randomized efficacy trial.

ROCA, A; Oluwalana, C; CAMARA, B; BOJANG, A; BURR, S; Davis, TM E; BAILEY, R; KAMPMANN, B; Mueller, J; BOTTOMLEY, C; D'ALESSANDRO, U;

2015

BMC pregnancy and childbirth, (2015).15 1 10.1186/s12884-015-0737-3.

Long-term impact of pneumococcal polysaccharide vaccination on nasopharyngeal carriage in children previously vaccinated with various pneumococcal conjugate vaccine regimes.

Boelsen, LK; Dunne, EM; Lamb, KE; Bright, K; Cheung, YB; Tikoduadua, L; Russell, FM; MULHOLLAND, EK; Licciardi, PV; Satzke, C;

2015

Vaccine, (2015).33 42 10.1016/j.vaccine.2015.07.059.

Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach.

CAMACHO, A; EGGO, RM; FUNK, S; WATSON, CH; KUCHARSKI, AJ; EDMUNDS, WJ;

2015

BMJ open, (2015).5 12 10.1136/bmjopen-2015-009346.

Continuing effectiveness of serogroup A meningococcal conjugate vaccine, Chad, 2013.

Gamougam, K; Daugla, DM; Toralta, J; Ngadoua, C; Fermon, F; Page, A-L; Djingarey, MH; Caugant, DA; MANIGART, O; Trotter, CL; Stuart, JM; GREENWOOD, BM;

2015

Emerging infectious diseases, (2015).21 1 10.3201/eid2101.140256.

PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.

Binks, MJ; Moberley, SA; Balloch, A; Leach, AJ; Nelson, S; Hare, KM; Wilson, C; Morris, PS; Nelson, J; Chatfield, MD; Tang, ML K; Torzillo, P; Carapetis, JR; MULHOLLAND, EK; Andrews, RM;

2015

Vaccine, (2015).33 48 10.1016/j.vaccine.2015.10.101.

Oral cholera vaccines in endemic countries.

O'Leary, M; MULHOLLAND, K;

2015

Lancet, (2015).386 10001 10.1016/S0140-6736(15)60246-X.

Acute Cardiovascular Events after Herpes Zoster: A Self-Controlled Case Series Analysis in Vaccinated and Unvaccinated Older Residents of the United States.

MINASSIAN, C; THOMAS, SL; SMEETH, L; DOUGLAS, I; BRAUER, R; LANGAN, SM;

2015

PLoS medicine, (2015).12 12 10.1371/journal.pmed.1001919.